These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30598509)

  • 1. A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists.
    Patil R; Mohanty B; Liu B; Chandrashekaran IR; Headey SJ; Williams ML; Clements CS; Ilyichova O; Doak BC; Genissel P; Weaver RJ; Vuillard L; Halls ML; Porter CJH; Scanlon MJ
    J Biol Chem; 2019 Mar; 294(10):3720-3734. PubMed ID: 30598509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor α in a Ligand-selective Manner.
    Hughes ML; Liu B; Halls ML; Wagstaff KM; Patil R; Velkov T; Jans DA; Bunnett NW; Scanlon MJ; Porter CJ
    J Biol Chem; 2015 May; 290(22):13895-906. PubMed ID: 25847235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway.
    Nakaya K; Tohyama J; Naik SU; Tanigawa H; MacPhee C; Billheimer JT; Rader DJ
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1276-82. PubMed ID: 21441141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism.
    Sharifpanah F; Wartenberg M; Hannig M; Piper HM; Sauer H
    Stem Cells; 2008 Jan; 26(1):64-71. PubMed ID: 17951219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
    Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
    Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation.
    van der Krieken SE; Popeijus HE; Konings M; Dullens SP; Mensink RP; Plat J
    J Cell Biochem; 2017 Apr; 118(4):754-763. PubMed ID: 27618583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA).
    Strömqvist M; Olsson JA; Kärrman A; Brunström B
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun; 156(1):29-36. PubMed ID: 22465071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease.
    Guzmán C; Benet M; Pisonero-Vaquero S; Moya M; García-Mediavilla MV; Martínez-Chantar ML; González-Gallego J; Castell JV; Sánchez-Campos S; Jover R
    Biochim Biophys Acta; 2013 Apr; 1831(4):803-18. PubMed ID: 23318274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes.
    Lee JY; Hashizaki H; Goto T; Sakamoto T; Takahashi N; Kawada T
    Biochem Biophys Res Commun; 2011 Apr; 407(4):818-22. PubMed ID: 21443859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells.
    Muoio DM; Way JM; Tanner CJ; Winegar DA; Kliewer SA; Houmard JA; Kraus WE; Dohm GL
    Diabetes; 2002 Apr; 51(4):901-9. PubMed ID: 11916905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis.
    Yan T; Luo Y; Yan N; Hamada K; Zhao N; Xia Y; Wang P; Zhao C; Qi D; Yang S; Sun L; Cai J; Wang Q; Jiang C; Gavrilova O; Krausz KW; Patel DP; Yu X; Wu X; Hao H; Liu W; Qu A; Gonzalez FJ
    Hepatology; 2023 Jan; 77(1):239-255. PubMed ID: 35460276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
    Paukkeri EL; Leppänen T; Sareila O; Vuolteenaho K; Kankaanranta H; Moilanen E
    Br J Pharmacol; 2007 Dec; 152(7):1081-91. PubMed ID: 17891158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-alpha control of lipid and glucose metabolism in human white adipocytes.
    Ribet C; Montastier E; Valle C; Bezaire V; Mazzucotelli A; Mairal A; Viguerie N; Langin D
    Endocrinology; 2010 Jan; 151(1):123-33. PubMed ID: 19887568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR-α agonist regulates amyloid-β generation via inhibiting BACE-1 activity in human neuroblastoma SH-SY5Y cells transfected with APPswe gene.
    Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y
    Mol Cell Biochem; 2015 Oct; 408(1-2):37-46. PubMed ID: 26092426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-α activation in cultured human female hepatocytes.
    McIntosh AL; Huang H; Storey SM; Landrock KK; Landrock D; Petrescu AD; Gupta S; Atshaves BP; Kier AB; Schroeder F
    Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G164-76. PubMed ID: 24875102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subfunctionalization of peroxisome proliferator response elements accounts for retention of duplicated fabp1 genes in zebrafish.
    Laprairie RB; Denovan-Wright EM; Wright JM
    BMC Evol Biol; 2016 Jul; 16(1):147. PubMed ID: 27421266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.
    van der Meer DL; Degenhardt T; Väisänen S; de Groot PJ; Heinäniemi M; de Vries SC; Müller M; Carlberg C; Kersten S
    Nucleic Acids Res; 2010 May; 38(9):2839-50. PubMed ID: 20110263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating PPARα prevents post-ischemic contractile dysfunction in hypertrophied neonatal hearts.
    Lam VH; Zhang L; Huqi A; Fukushima A; Tanner BA; Onay-Besikci A; Keung W; Kantor PF; Jaswal JS; Rebeyka IM; Lopaschuk GD
    Circ Res; 2015 Jun; 117(1):41-51. PubMed ID: 25977309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.
    Okishio S; Yamaguchi K; Ishiba H; Tochiki N; Yano K; Takahashi A; Kataoka S; Okuda K; Seko Y; Liu Y; Fujii H; Takahashi D; Ito Y; Kamon J; Umemura A; Moriguchi M; Yasui K; Okanoue T; Itoh Y
    Sci Rep; 2020 Nov; 10(1):19578. PubMed ID: 33177546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.